Antazoline
Back to searchMolecule Structure
Scientific Name
Antazoline
Description of the Drug
Antazoline is an antihistamine agent used for the symptomatic treatment of nasal congestion and allergic conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08799
http://www.drugbank.ca/drugs/DB08799
Brand Name(s)
Antaz sulf, Vasocon-a
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL9437 | ||
| Human Metabolome Database | HMDB0015689 | ||
| DrugBank | DB08799 | ||
| PubChem: Thomson Pharma | 15070645 | ||
| PubChem | 2200 | ||
| Mcule | MCULE-7710878667 | ||
| LINCS | LSM-6023 | ||
| Nikkaji | J4.345A | ||
| BindingDB | 76862 | ||
| EPA CompTox Dashboard | DTXSID3022613 | ||
| DrugCentral | 224 | ||
| ChemicalBook | CB8667315 | ||
| Guide to Pharmacology | 7116 | ||
| rxnorm | ANTAZOLINE HYDROCHLORIDE | ANTAZOLINE | ANTAZOLINE PHOSPHATE |
| ChEBI | 84115 | ||
| ZINC | ZINC000000057204 |
